IPO Watch: COVID-19 sell-off leaves just one survivor

Almost none of the ASX’s 2020 listings have been left unscathed by the market panic brought on by the COVID-19 pandemic.

Stockhead’s latest set of data shows that software platform COSOL (ASX:COS) is now the only company with shares still trading above its listing price.

Emerald Clinics (ASX:EMD) is the biggest loser, sinking 80 per cent since its debut in February.

New listings often face a rough time on the market and with the massive sell-offs on the ASX, it’s not surprising that all but one of this year’s listings are now trading below their IPO prices.

Here’s a performance rundown of this year’s ASX entrants:

UPCOMING IPOs

The market uncertainty has already claimed its first scalp with technology play Way 2 Vat Ltd withdrawing its $15m IPO.

There are still a number of companies on the ASX’s “pending” list but the coming weeks will be telling on whether these will go ahead or not.

Here’s a list of upcoming IPOs: